Table 1.
Baseline characteristics.
| Median (interquartile range) or %[n] | T2DM (n = 14) | Non T2DM (n = 14) | P value |
|---|---|---|---|
| Demographic data: | |||
| Age, years | 62 (51–68) | 54 (51–63) | 0.401 |
| Male gender, | 71.4 [10] | 92.9 [13] | 0.331 |
| Body mass index, kg/m2 | 33.4(29.3-43.4) | 30.6 (27.4-30.7) | 0.114 |
| Waist to hip ratio | 1.0(0.9-1.0) | 1.0(0.9-1.0) | 0.781 |
| Systolic BP, mmHg | 134 (124–147) | 120 (112–136) | 0.031 |
| Diastolic BP, mmHg | 77(72–82) | 72 (68–80) | 0.227 |
| Risk profile %(n): | |||
| Hypertension | 64.3 [9] | 21.4 [3] | 0.052 |
| Chronic Kidney Disease | 21.4 [3] | 7.1 [1] | 0.601 |
| Medications: | |||
| B blockers | 85.7 [12] | 100 [14] | 0.483 |
| Calcium channel blockers | 28.6 [4] | 7.1 [1] | 0.331 |
| Laboratory data: | |||
| HbA1c, % | 6.6 (6.2 -8.2) | 5.6 (5.3-6.1) | -- |
| Random plasma glucose, mmol/l | 8.2 (6.3-11.4) | 6.9 (4.9 -7.8) | -- |
| Fasting plasma glucose, mmol/l | 7.3 (5.6-10.9) | 5.1 (4.6-5.5) | -- |
| Haemoglobin, g/dl | 13.8 (12.8-15.4) | 13.7 (12.9-15.3) | 0.865 |
| Platelets, x1000/mm3 | 252 (191–309) | 257 (209–354) | 0.448 |
| Fibrinogen, g/l | 4.4 (4.1-4.6) | 3.6 (2.9-4.4) | 0.095 |
| Creatinine, μmol/l | 100(86–110) | 99 (81–106) | 0.6030 |
| Demographic data: | |||
| Total cholesterol, mmol/l | 3.2 (2.6-4.4) | 3.4 (3.0-4.0) | 0.667 |
| LDLc, mmol/l | 1.3 (1.0-1.7) | 1.9 (1.6-2.5) | 0.023 |
| HDLc, mmol/l | 0.9 (0.7-1.1) | 0.9 (0.8-1.2) | 0.769 |
| Triglyceride, mmol/l | 1.8 (1.4-3.4) | 1.1 (0.9 -1.5) | 0.002 |
| Troponin I, μg/l | 1.2 (0.1 – 10.1) | 2.0 (1.1-4.1) | 0.408 |